Why on earth is Craig Biggio above steroid suspicion?

71 Comments

Here we have Bill Madden’s latest gem of a column, which contains enough strawmen to fill up Citi Field. In it, he promotes Jack Morris and Craig Biggio for the Hall of Fame, and while he doesn’t unequivocally state that they are the only two players he is voting for, the column certainly suggests it.

I’ve tackled Morris before and will again tomorrow, but let’s concentrate on Biggio for a moment. Biggio is being promoted by Madden and others as this year’s clean candidate, whereas his longtime Astros teammate, Jeff Bagwell, has had his candidacy tainted by steroids.

What I don’t get is why one if not the other?

The case against Bagwell is that he showed little power as a youngster, befriended noted steroids user Ken Caminti, got a lot stronger in the majors and then turned into one of the game’s best players.

And that differs from Biggio how? Biggio hit four homers in 555 at-bats at age 24, four homers in 546 at-bats at age 25 and six homers in 613 at-bats at age 26 before turning in the first of seven 20-homer campaigns at age 27.  His career high of 26 homers came at age 39.

Furthermore, Bagwell and Biggio were good friends who spent 15 years as teammates. I have my doubts that the training methods of one were a secret to the other. If Bagwell was on something, one would think there’s a more than slight chance that Biggio was on it, too.

So why does Biggio get trumped up as clean? Because he was a middle infielder? Because he hit 20 homers per year rather than 40? I’ll give you that Biggio wasn’t quite as stacked as Bagwell in his prime, but the guy had some muscles.

Personally, I’m very much in favor of putting Biggio into the Hall, just as I’m in favor of Bagwell’s candidacy. Part of Biggio’s power spike can be attributed to him leaving the Astrodome for Enron Field/Minute Maid Park. Towards the end of his career, once he realized he could no longer cover the entire plate, he made a conscious decision to become more of a pull hitter and take aim at the shallow left field porch at Enron.

Biggio was a favorite of mine, and I’d like to think he spent his entire career steroid-free. My point here isn’t to label Biggio a cheater. It’s simply to say that we don’t know, and that anyone that would go to lengths to promote him as the clean candidate is either naive or stupid.

Blue Jays sign Michael Saunders

Getty Images
Leave a comment

The Blue Jays have signed outfielder Michael Saunders to a minor-league deal, per a club announcement.

Saunders, of course, played for the Blue Jays in 2015 and 2016, putting up a line of .250/.336/.461 in 594 plate appearances. It was his good play in the first half of 2016, in fact, which earned him an All-Star spot and, presumably, made the Phillies think he was worth the $9 million deal they gave him over the offseason. That didn’t work out, as he hit .205/.257/.360 over 61 games and was released last week.

The Phillies will pay the rest of that $9 million. The Jays will see if he has anything in the tank to help them out.

Giants closer Mark Melancon is heading to the disabled list once again

Getty Images
Leave a comment

The Giants have placed closer Mark Melancon on the 10-day disabled list with a right pronator strain.

This is the same injury that sent him to the disabled list last month. He came back from that quickly, but it can’t be great that this is happening again. You have to assume he’ll miss more time given the recurrence of trouble. He’s going to get an MRI too. Sam Dyson is expected to serve as the Giants’ closer while Melancon is sidelined.

Melancon has a 4.35 ERA and 11 saves in 22 appearances this year. He signed a four-year, $62 million deal with San Francisco last December.